Advertisement · 728 × 90

Posts by Kimberley Youkhana MD MSCR

Preview
FDA Investigating Death Due to Neutralizing Antibodies to ADAMTS13... Since approval, the Food and Drug Administration (FDA) has received postmarketing reports of neutralizing antibodies to ADAMTS13, including one death, in congenital thrombotic thrombocytopenic purpura...

Hello #benignheme community. I am curious of the recent #FDA investigation about #Adzynma influences you to make any changes and what were those changes in your recommendation about the product www.fda.gov/vaccines-blo...

4 months ago 0 0 0 0

I have already started sharing. Our newest NP said this was one of the most useful documents of the topic 😉

1 year ago 1 0 0 0
Post image

Thank you #HTRS for providing this immersive experience discussing #vWD from theory to clinical practice at @lunduniversity.bsky.social engaging the evidence, guidelines, and world wide perspectives and now meeting new #BenignHeme colleagues from the US @rushadpatell.bsky.social & Canada!

1 year ago 1 1 0 0
Post image

Should we increase preventive measures such as the use of a humidifier and #TxA with every episode of #epistaxis or #HMB or should we use prophylaxis in patients with #vWD and persistent bleeding that interfere with their lives? There may be benefit to prophylaxis ashpublications.org/bloodadvance...

1 year ago 1 0 0 0

This was very helpful thank you.

1 year ago 1 0 0 0
Post image Post image Post image Post image

The day is finally here 🤗!! The #vWD course from theory to clinical practice! Thank you @htrstoday.bsky.social and @lunduniversity.bsky.social. Oh the things we will learn.

1 year ago 2 1 0 0

Attention healthcare providers! AC Forum and FWGBD have just released an important new document on the care of folks with periods (or potential for periods) on anticoagulation! Check it out!
acforum.org/web/resource...

1 year ago 1 1 1 0
Preview
Real-World Experience with Emicizumab for Hemophilia a from the Physician Perspective Based on Survey Data Disclosures. Recht:Genentech, Inc.: Consultancy. Salehi:Adelphi Real World: Current Employment. Blazos:Adelphi Real World: Current Employment. Lai:Adelphi

ashpublications.org/blood/articl...

1 year ago 1 0 0 0
Post image

A patient with no prior bleeding history, develops unexplained bleeding, high PTT, lowFVIII and a FVIII inhibitor.😳 Do you let them
Bleed, immunosuppress them- if so with what? Do you give them emicizumab? Dr Jacqueline Poston explains in “Advances in Acquired Hemophilia A”. #AHA #BenignHeme

1 year ago 1 0 1 0
Advertisement
Post image Post image
1 year ago 1 0 0 0
Post image

>100k in the US, >4500 in SC have Sickle Cell Disease, the highest cause of 30-day readmission. Prioritizing #thalassemia and #scd care can make a difference. Dr Liz Traxler shares “Treatment and Emerging Therapies for SCD and Thalassemia” at today’s MUSC Multidisciplinary Heme Updates! #benignheme

1 year ago 1 0 1 0